img

Global Genomic Cancer Testing Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Genomic Cancer Testing Market Insights, Forecast to 2034

Market Analysis and InsightsGlobal Genomic Cancer Testing Market
Global Genomic Cancer Testing market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Genomic Cancer Testing industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
Globally, Genomic Cancer Testing key companies include Devyser, Agendia, Illumina, Personal Genome Diagnostics, Veracyte, Pacific Biosciences of California, Qiagen, Agilent Technologies and Natera, etc. Devyser, Agendia, Illumina are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Genomic Cancer Testing were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the share will be % in 2033. Moreover, China, plays a key role in the whole Genomic Cancer Testing market and estimated to attract more attentions from industry insiders and investors.
Genomic Cancer Testing can be divided into Fluorescence In Situ Hybridization, Polymerase Chain Reaction, Microarray Technology and Serum Proteomics, etc. Fluorescence In Situ Hybridization is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2033.
Genomic Cancer Testing is widely used in various fields, such as Hospitals, Speciality Clinics, Research Institutes and Diagnostics Laboratories, etc. Hospitals provides greatest supports to the Genomic Cancer Testing industry development. In 2022, global % revenue of Genomic Cancer Testing went into Hospitals filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global Genomic Cancer Testing market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Genomic Cancer Testing market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Devyser
Agendia
Illumina
Personal Genome Diagnostics
Veracyte
Pacific Biosciences of California
Qiagen
Agilent Technologies
Natera
Bio Rad Laboratories
Myriad Genetics
Segment by Type
Fluorescence In Situ Hybridization
Polymerase Chain Reaction
Microarray Technology
Serum Proteomics
Nucleic Acid Sequencing

Segment by Application


Hospitals
Speciality Clinics
Research Institutes
Diagnostics Laboratories
Biopharmaceutical Companies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Genomic Cancer Testing introduction, etc. Genomic Cancer Testing Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Genomic Cancer Testing
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Genomic Cancer Testing Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Fluorescence In Situ Hybridization
1.2.3 Polymerase Chain Reaction
1.2.4 Microarray Technology
1.2.5 Serum Proteomics
1.2.6 Nucleic Acid Sequencing
1.3 Market by Application
1.3.1 Global Genomic Cancer Testing Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Speciality Clinics
1.3.4 Research Institutes
1.3.5 Diagnostics Laboratories
1.3.6 Biopharmaceutical Companies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Genomic Cancer Testing Market Perspective (2018-2033)
2.2 Global Genomic Cancer Testing Growth Trends by Region
2.2.1 Genomic Cancer Testing Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Genomic Cancer Testing Historic Market Size by Region (2018-2023)
2.2.3 Genomic Cancer Testing Forecasted Market Size by Region (2024-2033)
2.3 Genomic Cancer Testing Market Dynamics
2.3.1 Genomic Cancer Testing Industry Trends
2.3.2 Genomic Cancer Testing Market Drivers
2.3.3 Genomic Cancer Testing Market Challenges
2.3.4 Genomic Cancer Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Genomic Cancer Testing by Players
3.1.1 Global Genomic Cancer Testing Revenue by Players (2018-2023)
3.1.2 Global Genomic Cancer Testing Revenue Market Share by Players (2018-2023)
3.2 Global Genomic Cancer Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Genomic Cancer Testing, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Genomic Cancer Testing Market Concentration Ratio
3.4.1 Global Genomic Cancer Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Genomic Cancer Testing Revenue in 2022
3.5 Global Key Players of Genomic Cancer Testing Head office and Area Served
3.6 Global Key Players of Genomic Cancer Testing, Product and Application
3.7 Global Key Players of Genomic Cancer Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Genomic Cancer Testing Breakdown Data by Type
4.1 Global Genomic Cancer Testing Historic Market Size by Type (2018-2023)
4.2 Global Genomic Cancer Testing Forecasted Market Size by Type (2024-2033)
5 Genomic Cancer Testing Breakdown Data by Application
5.1 Global Genomic Cancer Testing Historic Market Size by Application (2018-2023)
5.2 Global Genomic Cancer Testing Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Genomic Cancer Testing Market Size (2018-2033)
6.2 North America Genomic Cancer Testing Market Size by Type
6.2.1 North America Genomic Cancer Testing Market Size by Type (2018-2023)
6.2.2 North America Genomic Cancer Testing Market Size by Type (2024-2033)
6.2.3 North America Genomic Cancer Testing Market Share by Type (2018-2033)
6.3 North America Genomic Cancer Testing Market Size by Application
6.3.1 North America Genomic Cancer Testing Market Size by Application (2018-2023)
6.3.2 North America Genomic Cancer Testing Market Size by Application (2024-2033)
6.3.3 North America Genomic Cancer Testing Market Share by Application (2018-2033)
6.4 North America Genomic Cancer Testing Market Size by Country
6.4.1 North America Genomic Cancer Testing Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Genomic Cancer Testing Market Size by Country (2018-2023)
6.4.3 North America Genomic Cancer Testing Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Genomic Cancer Testing Market Size (2018-2033)
7.2 Europe Genomic Cancer Testing Market Size by Type
7.2.1 Europe Genomic Cancer Testing Market Size by Type (2018-2023)
7.2.2 Europe Genomic Cancer Testing Market Size by Type (2024-2033)
7.2.3 Europe Genomic Cancer Testing Market Share by Type (2018-2033)
7.3 Europe Genomic Cancer Testing Market Size by Application
7.3.1 Europe Genomic Cancer Testing Market Size by Application (2018-2023)
7.3.2 Europe Genomic Cancer Testing Market Size by Application (2024-2033)
7.3.3 Europe Genomic Cancer Testing Market Share by Application (2018-2033)
7.4 Europe Genomic Cancer Testing Market Size by Country
7.4.1 Europe Genomic Cancer Testing Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Genomic Cancer Testing Market Size by Country (2018-2023)
7.4.3 Europe Genomic Cancer Testing Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Genomic Cancer Testing Market Size (2018-2033)
8.2 China Genomic Cancer Testing Market Size by Type
8.2.1 China Genomic Cancer Testing Market Size by Type (2018-2023)
8.2.2 China Genomic Cancer Testing Market Size by Type (2024-2033)
8.2.3 China Genomic Cancer Testing Market Share by Type (2018-2033)
8.3 China Genomic Cancer Testing Market Size by Application
8.3.1 China Genomic Cancer Testing Market Size by Application (2018-2023)
8.3.2 China Genomic Cancer Testing Market Size by Application (2024-2033)
8.3.3 China Genomic Cancer Testing Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Genomic Cancer Testing Market Size (2018-2033)
9.2 Asia Genomic Cancer Testing Market Size by Type
9.2.1 Asia Genomic Cancer Testing Market Size by Type (2018-2023)
9.2.2 Asia Genomic Cancer Testing Market Size by Type (2024-2033)
9.2.3 Asia Genomic Cancer Testing Market Share by Type (2018-2033)
9.3 Asia Genomic Cancer Testing Market Size by Application
9.3.1 Asia Genomic Cancer Testing Market Size by Application (2018-2023)
9.3.2 Asia Genomic Cancer Testing Market Size by Application (2024-2033)
9.3.3 Asia Genomic Cancer Testing Market Share by Application (2018-2033)
9.4 Asia Genomic Cancer Testing Market Size by Region
9.4.1 Asia Genomic Cancer Testing Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Genomic Cancer Testing Market Size by Region (2018-2023)
9.4.3 Asia Genomic Cancer Testing Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Genomic Cancer Testing Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Genomic Cancer Testing Market Size by Type
10.2.1 Middle East, Africa, and Latin America Genomic Cancer Testing Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Genomic Cancer Testing Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Genomic Cancer Testing Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Genomic Cancer Testing Market Size by Application
10.3.1 Middle East, Africa, and Latin America Genomic Cancer Testing Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Genomic Cancer Testing Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Genomic Cancer Testing Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Genomic Cancer Testing Market Size by Country
10.4.1 Middle East, Africa, and Latin America Genomic Cancer Testing Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Genomic Cancer Testing Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Genomic Cancer Testing Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Devyser
11.1.1 Devyser Company Details
11.1.2 Devyser Business Overview
11.1.3 Devyser Genomic Cancer Testing Introduction
11.1.4 Devyser Revenue in Genomic Cancer Testing Business (2018-2023)
11.1.5 Devyser Recent Developments
11.2 Agendia
11.2.1 Agendia Company Details
11.2.2 Agendia Business Overview
11.2.3 Agendia Genomic Cancer Testing Introduction
11.2.4 Agendia Revenue in Genomic Cancer Testing Business (2018-2023)
11.2.5 Agendia Recent Developments
11.3 Illumina
11.3.1 Illumina Company Details
11.3.2 Illumina Business Overview
11.3.3 Illumina Genomic Cancer Testing Introduction
11.3.4 Illumina Revenue in Genomic Cancer Testing Business (2018-2023)
11.3.5 Illumina Recent Developments
11.4 Personal Genome Diagnostics
11.4.1 Personal Genome Diagnostics Company Details
11.4.2 Personal Genome Diagnostics Business Overview
11.4.3 Personal Genome Diagnostics Genomic Cancer Testing Introduction
11.4.4 Personal Genome Diagnostics Revenue in Genomic Cancer Testing Business (2018-2023)
11.4.5 Personal Genome Diagnostics Recent Developments
11.5 Veracyte
11.5.1 Veracyte Company Details
11.5.2 Veracyte Business Overview
11.5.3 Veracyte Genomic Cancer Testing Introduction
11.5.4 Veracyte Revenue in Genomic Cancer Testing Business (2018-2023)
11.5.5 Veracyte Recent Developments
11.6 Pacific Biosciences of California
11.6.1 Pacific Biosciences of California Company Details
11.6.2 Pacific Biosciences of California Business Overview
11.6.3 Pacific Biosciences of California Genomic Cancer Testing Introduction
11.6.4 Pacific Biosciences of California Revenue in Genomic Cancer Testing Business (2018-2023)
11.6.5 Pacific Biosciences of California Recent Developments
11.7 Qiagen
11.7.1 Qiagen Company Details
11.7.2 Qiagen Business Overview
11.7.3 Qiagen Genomic Cancer Testing Introduction
11.7.4 Qiagen Revenue in Genomic Cancer Testing Business (2018-2023)
11.7.5 Qiagen Recent Developments
11.8 Agilent Technologies
11.8.1 Agilent Technologies Company Details
11.8.2 Agilent Technologies Business Overview
11.8.3 Agilent Technologies Genomic Cancer Testing Introduction
11.8.4 Agilent Technologies Revenue in Genomic Cancer Testing Business (2018-2023)
11.8.5 Agilent Technologies Recent Developments
11.9 Natera
11.9.1 Natera Company Details
11.9.2 Natera Business Overview
11.9.3 Natera Genomic Cancer Testing Introduction
11.9.4 Natera Revenue in Genomic Cancer Testing Business (2018-2023)
11.9.5 Natera Recent Developments
11.10 Bio Rad Laboratories
11.10.1 Bio Rad Laboratories Company Details
11.10.2 Bio Rad Laboratories Business Overview
11.10.3 Bio Rad Laboratories Genomic Cancer Testing Introduction
11.10.4 Bio Rad Laboratories Revenue in Genomic Cancer Testing Business (2018-2023)
11.10.5 Bio Rad Laboratories Recent Developments
11.11 Myriad Genetics
11.11.1 Myriad Genetics Company Details
11.11.2 Myriad Genetics Business Overview
11.11.3 Myriad Genetics Genomic Cancer Testing Introduction
11.11.4 Myriad Genetics Revenue in Genomic Cancer Testing Business (2018-2023)
11.11.5 Myriad Genetics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Genomic Cancer Testing Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Fluorescence In Situ Hybridization
Table 3. Key Players of Polymerase Chain Reaction
Table 4. Key Players of Microarray Technology
Table 5. Key Players of Serum Proteomics
Table 6. Key Players of Nucleic Acid Sequencing
Table 7. Global Genomic Cancer Testing Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 8. Global Genomic Cancer Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 9. Global Genomic Cancer Testing Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Genomic Cancer Testing Market Share by Region (2018-2023)
Table 11. Global Genomic Cancer Testing Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 12. Global Genomic Cancer Testing Market Share by Region (2024-2033)
Table 13. Genomic Cancer Testing Market Trends
Table 14. Genomic Cancer Testing Market Drivers
Table 15. Genomic Cancer Testing Market Challenges
Table 16. Genomic Cancer Testing Market Restraints
Table 17. Global Genomic Cancer Testing Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Genomic Cancer Testing Revenue Share by Players (2018-2023)
Table 19. Global Top Genomic Cancer Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genomic Cancer Testing as of 2022)
Table 20. Global Genomic Cancer Testing Industry Ranking 2021 VS 2022 VS 2023
Table 21. Global 5 Largest Players Market Share by Genomic Cancer Testing Revenue (CR5 and HHI) & (2018-2023)
Table 22. Global Key Players of Genomic Cancer Testing, Headquarters and Area Served
Table 23. Global Key Players of Genomic Cancer Testing, Product and Application
Table 24. Global Key Players of Genomic Cancer Testing, Product and Application
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Genomic Cancer Testing Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Genomic Cancer Testing Revenue Market Share by Type (2018-2023)
Table 28. Global Genomic Cancer Testing Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 29. Global Genomic Cancer Testing Revenue Market Share by Type (2024-2033)
Table 30. Global Genomic Cancer Testing Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Genomic Cancer Testing Revenue Share by Application (2018-2023)
Table 32. Global Genomic Cancer Testing Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 33. Global Genomic Cancer Testing Revenue Share by Application (2024-2033)
Table 34. North America Genomic Cancer Testing Market Size by Type (2018-2023) & (US$ Million)
Table 35. North America Genomic Cancer Testing Market Size by Type (2024-2033) & (US$ Million)
Table 36. North America Genomic Cancer Testing Market Size by Application (2018-2023) & (US$ Million)
Table 37. North America Genomic Cancer Testing Market Size by Application (2024-2033) & (US$ Million)
Table 38. North America Genomic Cancer Testing Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 39. North America Genomic Cancer Testing Market Size by Country (2018-2023) & (US$ Million)
Table 40. North America Genomic Cancer Testing Market Size by Country (2024-2033) & (US$ Million)
Table 41. Europe Genomic Cancer Testing Market Size by Type (2018-2023) & (US$ Million)
Table 42. Europe Genomic Cancer Testing Market Size by Type (2024-2033) & (US$ Million)
Table 43. Europe Genomic Cancer Testing Market Size by Application (2018-2023) & (US$ Million)
Table 44. Europe Genomic Cancer Testing Market Size by Application (2024-2033) & (US$ Million)
Table 45. Europe Genomic Cancer Testing Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Europe Genomic Cancer Testing Market Size by Country (2018-2023) & (US$ Million)
Table 47. Europe Genomic Cancer Testing Market Size by Country (2024-2033) & (US$ Million)
Table 48. China Genomic Cancer Testing Market Size by Type (2018-2023) & (US$ Million)
Table 49. China Genomic Cancer Testing Market Size by Type (2024-2033) & (US$ Million)
Table 50. China Genomic Cancer Testing Market Size by Application (2018-2023) & (US$ Million)
Table 51. China Genomic Cancer Testing Market Size by Application (2024-2033) & (US$ Million)
Table 52. Asia Genomic Cancer Testing Market Size by Type (2018-2023) & (US$ Million)
Table 53. Asia Genomic Cancer Testing Market Size by Type (2024-2033) & (US$ Million)
Table 54. Asia Genomic Cancer Testing Market Size by Application (2018-2023) & (US$ Million)
Table 55. Asia Genomic Cancer Testing Market Size by Application (2024-2033) & (US$ Million)
Table 56. Asia Genomic Cancer Testing Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 57. Asia Genomic Cancer Testing Market Size by Region (2018-2023) & (US$ Million)
Table 58. Asia Genomic Cancer Testing Market Size by Region (2024-2033) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Genomic Cancer Testing Market Size by Type (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Genomic Cancer Testing Market Size by Type (2024-2033) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Genomic Cancer Testing Market Size by Application (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Genomic Cancer Testing Market Size by Application (2024-2033) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Genomic Cancer Testing Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 64. Middle East, Africa, and Latin America Genomic Cancer Testing Market Size by Country (2018-2023) & (US$ Million)
Table 65. Middle East, Africa, and Latin America Genomic Cancer Testing Market Size by Country (2024-2033) & (US$ Million)
Table 66. Devyser Company Details
Table 67. Devyser Business Overview
Table 68. Devyser Genomic Cancer Testing Product
Table 69. Devyser Revenue in Genomic Cancer Testing Business (2018-2023) & (US$ Million)
Table 70. Devyser Recent Developments
Table 71. Agendia Company Details
Table 72. Agendia Business Overview
Table 73. Agendia Genomic Cancer Testing Product
Table 74. Agendia Revenue in Genomic Cancer Testing Business (2018-2023) & (US$ Million)
Table 75. Agendia Recent Developments
Table 76. Illumina Company Details
Table 77. Illumina Business Overview
Table 78. Illumina Genomic Cancer Testing Product
Table 79. Illumina Revenue in Genomic Cancer Testing Business (2018-2023) & (US$ Million)
Table 80. Illumina Recent Developments
Table 81. Personal Genome Diagnostics Company Details
Table 82. Personal Genome Diagnostics Business Overview
Table 83. Personal Genome Diagnostics Genomic Cancer Testing Product
Table 84. Personal Genome Diagnostics Revenue in Genomic Cancer Testing Business (2018-2023) & (US$ Million)
Table 85. Personal Genome Diagnostics Recent Developments
Table 86. Veracyte Company Details
Table 87. Veracyte Business Overview
Table 88. Veracyte Genomic Cancer Testing Product
Table 89. Veracyte Revenue in Genomic Cancer Testing Business (2018-2023) & (US$ Million)
Table 90. Veracyte Recent Developments
Table 91. Pacific Biosciences of California Company Details
Table 92. Pacific Biosciences of California Business Overview
Table 93. Pacific Biosciences of California Genomic Cancer Testing Product
Table 94. Pacific Biosciences of California Revenue in Genomic Cancer Testing Business (2018-2023) & (US$ Million)
Table 95. Pacific Biosciences of California Recent Developments
Table 96. Qiagen Company Details
Table 97. Qiagen Business Overview
Table 98. Qiagen Genomic Cancer Testing Product
Table 99. Qiagen Revenue in Genomic Cancer Testing Business (2018-2023) & (US$ Million)
Table 100. Qiagen Recent Developments
Table 101. Agilent Technologies Company Details
Table 102. Agilent Technologies Business Overview
Table 103. Agilent Technologies Genomic Cancer Testing Product
Table 104. Agilent Technologies Revenue in Genomic Cancer Testing Business (2018-2023) & (US$ Million)
Table 105. Agilent Technologies Recent Developments
Table 106. Natera Company Details
Table 107. Natera Business Overview
Table 108. Natera Genomic Cancer Testing Product
Table 109. Natera Revenue in Genomic Cancer Testing Business (2018-2023) & (US$ Million)
Table 110. Natera Recent Developments
Table 111. Bio Rad Laboratories Company Details
Table 112. Bio Rad Laboratories Business Overview
Table 113. Bio Rad Laboratories Genomic Cancer Testing Product
Table 114. Bio Rad Laboratories Revenue in Genomic Cancer Testing Business (2018-2023) & (US$ Million)
Table 115. Bio Rad Laboratories Recent Developments
Table 116. Myriad Genetics Company Details
Table 117. Myriad Genetics Business Overview
Table 118. Myriad Genetics Genomic Cancer Testing Product
Table 119. Myriad Genetics Revenue in Genomic Cancer Testing Business (2018-2023) & (US$ Million)
Table 120. Myriad Genetics Recent Developments
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Genomic Cancer Testing Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Genomic Cancer Testing Market Share by Type: 2022 VS 2033
Figure 3. Fluorescence In Situ Hybridization Features
Figure 4. Polymerase Chain Reaction Features
Figure 5. Microarray Technology Features
Figure 6. Serum Proteomics Features
Figure 7. Nucleic Acid Sequencing Features
Figure 8. Global Genomic Cancer Testing Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 9. Global Genomic Cancer Testing Market Share by Application: 2022 VS 2033
Figure 10. Hospitals Case Studies
Figure 11. Speciality Clinics Case Studies
Figure 12. Research Institutes Case Studies
Figure 13. Diagnostics Laboratories Case Studies
Figure 14. Biopharmaceutical Companies Case Studies
Figure 15. Genomic Cancer Testing Report Years Considered
Figure 16. Global Genomic Cancer Testing Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 17. Global Genomic Cancer Testing Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 18. Global Genomic Cancer Testing Market Share by Region: 2022 VS 2033
Figure 19. Global Genomic Cancer Testing Market Share by Players in 2022
Figure 20. Global Top Genomic Cancer Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genomic Cancer Testing as of 2022)
Figure 21. The Top 10 and 5 Players Market Share by Genomic Cancer Testing Revenue in 2022
Figure 22. North America Genomic Cancer Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. North America Genomic Cancer Testing Market Share by Type (2018-2033)
Figure 24. North America Genomic Cancer Testing Market Share by Application (2018-2033)
Figure 25. North America Genomic Cancer Testing Market Share by Country (2018-2033)
Figure 26. United States Genomic Cancer Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Canada Genomic Cancer Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Europe Genomic Cancer Testing Market Size YoY (2018-2033) & (US$ Million)
Figure 29. Europe Genomic Cancer Testing Market Share by Type (2018-2033)
Figure 30. Europe Genomic Cancer Testing Market Share by Application (2018-2033)
Figure 31. Europe Genomic Cancer Testing Market Share by Country (2018-2033)
Figure 32. Germany Genomic Cancer Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. France Genomic Cancer Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. U.K. Genomic Cancer Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Italy Genomic Cancer Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Russia Genomic Cancer Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Nordic Countries Genomic Cancer Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. China Genomic Cancer Testing Market Size YoY (2018-2033) & (US$ Million)
Figure 39. China Genomic Cancer Testing Market Share by Type (2018-2033)
Figure 40. China Genomic Cancer Testing Market Share by Application (2018-2033)
Figure 41. Asia Genomic Cancer Testing Market Size YoY (2018-2033) & (US$ Million)
Figure 42. Asia Genomic Cancer Testing Market Share by Type (2018-2033)
Figure 43. Asia Genomic Cancer Testing Market Share by Application (2018-2033)
Figure 44. Asia Genomic Cancer Testing Market Share by Region (2018-2033)
Figure 45. Japan Genomic Cancer Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. South Korea Genomic Cancer Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. China Taiwan Genomic Cancer Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Southeast Asia Genomic Cancer Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. India Genomic Cancer Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 50. Australia Genomic Cancer Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 51. Middle East, Africa, and Latin America Genomic Cancer Testing Market Size YoY (2018-2033) & (US$ Million)
Figure 52. Middle East, Africa, and Latin America Genomic Cancer Testing Market Share by Type (2018-2033)
Figure 53. Middle East, Africa, and Latin America Genomic Cancer Testing Market Share by Application (2018-2033)
Figure 54. Middle East, Africa, and Latin America Genomic Cancer Testing Market Share by Country (2018-2033)
Figure 55. Brazil Genomic Cancer Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Mexico Genomic Cancer Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. Turkey Genomic Cancer Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 58. Saudi Arabia Genomic Cancer Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 59. Israel Genomic Cancer Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 60. GCC Countries Genomic Cancer Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 61. Devyser Revenue Growth Rate in Genomic Cancer Testing Business (2018-2023)
Figure 62. Agendia Revenue Growth Rate in Genomic Cancer Testing Business (2018-2023)
Figure 63. Illumina Revenue Growth Rate in Genomic Cancer Testing Business (2018-2023)
Figure 64. Personal Genome Diagnostics Revenue Growth Rate in Genomic Cancer Testing Business (2018-2023)
Figure 65. Veracyte Revenue Growth Rate in Genomic Cancer Testing Business (2018-2023)
Figure 66. Pacific Biosciences of California Revenue Growth Rate in Genomic Cancer Testing Business (2018-2023)
Figure 67. Qiagen Revenue Growth Rate in Genomic Cancer Testing Business (2018-2023)
Figure 68. Agilent Technologies Revenue Growth Rate in Genomic Cancer Testing Business (2018-2023)
Figure 69. Natera Revenue Growth Rate in Genomic Cancer Testing Business (2018-2023)
Figure 70. Bio Rad Laboratories Revenue Growth Rate in Genomic Cancer Testing Business (2018-2023)
Figure 71. Myriad Genetics Revenue Growth Rate in Genomic Cancer Testing Business (2018-2023)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries